The new agreement gives Firmenich exclusive access to Amyris’ technology for the flavours and fragrance market outside of its existing relationships, in exchange for ‘significant’ funding over the next six years. Amyris modifies the way microorganisms process plant-sourced sugars, and then uses them to convert sugars into renewable hydrocarbons.
The two companies established an agreement in November 2010 to develop three flavour and fragrance ingredients, including a fragrance ingredient targeted for commercialisation early next year. Under the new agreement, the companies will jointly select other ingredients for development and manufacture. Firmenich will then market and distribute any resulting ingredients exclusively in the flavours and fragrances market.
Firmenich CEO Patrick Firmenich said in a statement: “This partnership leverages Firmenich’s world class biotechnology platform within the F&F industry, enabled by our leading team of molecular biologists and unique intellectual property, as well as, our deep client intimacy and market understanding. Innovation and sustainability are critical pillars of our business model.”
Amyris president and CEO John Melo said: “The rapid pace of our targeted ingredient development so far confirms our ability to deliver a host of disruptive, competitive ingredients to our partners and underscores the strategic value of collaborations for Amyris.”
The two companies have agreed to share in the sales value of ingredients resulting from the partnership.